Erectile physiological and pathophysiological pathways involved in erectile dysfunction
- PMID: 12853766
- DOI: 10.1097/01.ju.0000075362.08363.a4
Erectile physiological and pathophysiological pathways involved in erectile dysfunction
Abstract
Purpose: The importance of signaling pathways in penile smooth muscles involved in normal erection and erectile dysfunction (ED) is discussed based on a review of the literature.
Materials and methods: Erection is basically a spinal reflex that can be initiated by recruitment of penile afferents but also by visual, olfactory and imaginary stimuli. The generated nervous signals will influence the balance between the contractant and relaxant factors, which control the degree of contraction of penile smooth muscles and, thus, determine the functional state of the penis. The different steps involved in neurotransmission, impulse propagation and intracellular transduction of neural signals may be changed in different types of erectile dysfunction.
Results: Recent findings have suggested an important role for RhoA/Rho kinase in the regulation of cavernosal smooth muscle tone and that changes in this pathway may contribute to ED in various patient subgroups, eg diabetes and vascular disease. Neurogenic nitric oxide is still considered the most important factor for immediate relaxation of penile vessels and corpus cavernosum. However, endothelially generated nitric oxide seems essential for maintaining erection. Endothelial dysfunction can contribute to ED in several patient subgroups. In addition, in conditions associated with reduced function of nerves and endothelium, such as aging, hypertension, smoking, hypercholesterolemia and diabetes, circulatory and structural changes in the penile tissues can result in arterial insufficiency and defect muscle relaxation.
Conclusions: Different types of ED often have overlapping pathophysiologies but may also have common pathways contributing to ED. Such pathways may be potential treatment targets.
Similar articles
-
Rho-kinase and RGS-containing RhoGEFs as molecular targets for the treatment of erectile dysfunction.Curr Pharm Des. 2005;11(31):4029-40. doi: 10.2174/138161205774913390. Curr Pharm Des. 2005. PMID: 16378508 Review.
-
Pharmacology of penile erection.Pharmacol Rev. 2001 Sep;53(3):417-50. Pharmacol Rev. 2001. PMID: 11546836 Review.
-
[Cardiovascular risk factors, erection disorders and endothelium dysfunction].J Soc Biol. 2004;198(3):237-41. J Soc Biol. 2004. PMID: 15662940 Review. French.
-
Neurophysiology/pharmacology of erection.Int J Impot Res. 2001 Aug;13 Suppl 3:S8-S17. doi: 10.1038/sj.ijir.3900718. Int J Impot Res. 2001. PMID: 11477487 Review.
-
[Inhibition of tonic contraction of smooth muscle: a new approach to achieve erection dysfunction].Zhonghua Nan Ke Xue. 2002 Dec;8(6):391-4. Zhonghua Nan Ke Xue. 2002. PMID: 12593007 Chinese.
Cited by
-
Neural substrates of sexual arousal in heterosexual males: event-related fMRI investigation.J Physiol Anthropol. 2016 Mar 8;35:8. doi: 10.1186/s40101-016-0089-3. J Physiol Anthropol. 2016. PMID: 26951096 Free PMC article.
-
Association between composite dietary antioxidant index and erectile dysfunction among American adults: a cross-sectional study.Sci Rep. 2024 Sep 11;14(1):21230. doi: 10.1038/s41598-024-72157-w. Sci Rep. 2024. PMID: 39261605 Free PMC article.
-
Understanding and Managing Erectile Dysfunction in Patients Treated for Cancer.J Oncol Pract. 2016 Apr;12(4):297-304. doi: 10.1200/JOP.2016.010678. J Oncol Pract. 2016. PMID: 27072383 Free PMC article. Review.
-
MYPT1 reduction is a pathogenic factor of erectile dysfunction.Commun Biol. 2022 Jul 25;5(1):744. doi: 10.1038/s42003-022-03716-y. Commun Biol. 2022. PMID: 35879418 Free PMC article.
-
Lithium and Erectile Dysfunction: An Overview.Cells. 2022 Jan 5;11(1):171. doi: 10.3390/cells11010171. Cells. 2022. PMID: 35011733 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical